Concepedia

Author

Ana Lucía Rendón

Hospital Clínico San Carlos

Also Known As

A. Rendón, Ana L. Rendón, Ana Lucía Rendón, Ana Rendon, Ana Rendón

13

Publications

549

Citations

9

H-Index

22

Concepts

All Affiliations

Hospital Clínico San CarlosHospital de Sant PauInstituto de Salud Carlos III
AL

About

Ana Lucía Rendón is an author at Hospital Clínico San Carlos specializing in pharmacotherapy, hiv, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

96

2

Natural Sciences

1

1

24

3

Public Health

1

1

60

4

Biochemistry

1

1

24

5

Epidemiology

1

1

60

Ana Lucía Rendón

×

9

Publications

541

Citations

9

H-Index

YearCitations

Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges

Shambavi Subbarao, Ronald A. Otten, Artur Ramos,

The Journal of Infectious Diseases

2006

192

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

Ana Barrios, Ana Lucía Rendón, Eugènia Negredo,

AIDS

2005

83

Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients

Ana Lucía Rendón, Marina Núñez, Míriam Romero,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2005

75

Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

Ana Barrios, Ana Lucía Rendón, Óscar Gallego,

HIV Clinical Trials

2004

60

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV‐coinfected patients

Belén Ramos, Marina Núñez, Ana Lucía Rendón,

Journal of Viral Hepatitis

2006

40

Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir

Teresa García-Benayas, Ana Lucía Rendón, Sonia Rodríguez‐Nóvoa,

AIDS Research and Human Retroviruses

2006

28

An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean

Aimeé Salas-Hernández, Macarena Galleguillos, Matías Carrasco,

Frontiers in Pharmacology

2023

27

Combinations of nucleoside/nucleotide analogues for HIV therapy.

Pablo Barreiro, Teresa García-Benayas, Ana Lucía Rendón,

PubMed

2005

24

Pharmacogenetics in HIV therapy.

Sonia Rodríguez‐Nóvoa, Pablo Barreiro, Inmaculada Jiménez‐Nácher,

PubMed

2005

12

Page 1